Inventor · disambiguated record
Sreenivasu Mudumba
Also filed as: MUDUMBA SREENIVASU
15 granted patents·13 pending applications·237 citations·filing 2002–2020
93Inventor score
Files withSANTEN PHARMACEUTICAL CO LTD11MACUSIGHT INC6DURECT CORP4MUDUMBA SREENIVASU3COOPER EUGENE R1
Top patents by PatentIndex Score
28 records- 0195US8367097B2Liquid formulations for treatment of diseases or conditionsSANTEN PHARMACEUTICAL CO LTD·Filed 2010·Granted Feb 5, 2013·31 cites·14 claims
- 0295US7585517B2Transscleral deliveryMACUSIGHT INC·Filed 2004·Granted Sep 8, 2009·101 cites·31 claims
- 0394US8927005B2Liquid formulations for treatment of diseases or conditionsSANTEN PHARMACEUTICAL CO LTD·Filed 2013·Granted Jan 6, 2015·20 cites·20 claims
- 0490US8663639B2Formulations for treating ocular diseases and conditionsDOR PHILIPPE J M·Filed 2008·Granted Mar 4, 2014·37 cites·11 claims
- 0589US10682340B2Depot formulationsDURECT CORP·Filed 2017·Granted Jun 16, 2020·4 cites·19 claims
- 0683US9387165B2Rapamycin formulations and methods of their useSANTEN PHARMACEUTICAL CO LTD·Filed 2014·Granted Jul 12, 2016·3 cites·7 claims
- 0782US11013731B2Intratumoral administration of sirolimus for treatment of prostate cancerSANTEN PHARMACEUTICAL CO LTD·Filed 2017·Granted May 25, 2021·5 cites·19 claims
- 0882US8637070B2Rapamycin formulations and methods of their useMUDUMBA SREENIVASU·Filed 2006·Granted Jan 28, 2014·4 cites·8 claims
- 0981US8492400B2Stable formulations, and methods of their preparation and useMUDUMBA SREENIVASU·Filed 2007·Granted Jul 23, 2013·6 cites·26 claims
- 1080US10668011B2Depot formulationsDURECT CORP·Filed 2017·Granted Jun 2, 2020·1 cites·10 claims
- 1176US9381153B2Liquid formulations for treatment of diseases or conditionsSANTEN PHARMACEUTICAL CO LTD·Filed 2014·Granted Jul 5, 2016·1 cites·2 claims
- 1274US8658667B2Stable formulations, and methods of their preparation and useSANTEN PHARMACEUTICAL CO LTD·Filed 2013·Granted Feb 25, 2014·2 cites·23 claims
- 1374US7976867B2Dermal, transdermal, mucosal or transmucosal ingredient delivery devicesSCHERING PLOUGH HEALTHCARE·Filed 2003·Granted Jul 12, 2011·5 cites·12 claims
- 1467US2009324686A1Transscleral deliveryMACUSIGHT INC·Filed 2009·Application pending·0 cites
- 1567US2009324688A1Transscleral deliveryMACUSIGHT INC·Filed 2009·Application pending·0 cites
- 1667US2009324687A1Transscleral deliveryMACUSIGHT INC·Filed 2009·Application pending·0 cites
- 1767US2009324690A1Transscleral deliveryMACUSIGHT INC·Filed 2009·Application pending·0 cites
- 1867US2009324689A1Transscleral deliveryMACUSIGHT INC·Filed 2009·Application pending·0 cites
- 1965US2018311152A1Liquid formulations for treatment of diseases or conditionsSANTEN PHARMACEUTICAL CO LTD·Filed 2017·Application pending·0 cites
- 2064US2017266109A1Rapamycin formulations and methods of their useSANTEN PHARMACEUTICAL CO LTD·Filed 2017·Application pending·0 cites
- 2162US2016303093A1Rapamycin formulations and methods of their useSANTEN PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
- 2261US2017020809A1Liquid formulations for treatment of diseases or conditionsSANTEN PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
- 2358US8956160B2Device and method for delivering an oral care agentWILLISON MICHAEL P·Filed 2002·Granted Feb 17, 2015·17 cites·157 claims
- 2458US2020383957A1Depot formulationsDURECT CORP·Filed 2020·Application pending·0 cites
- 2558US2020352852A1Depot formulationsDURECT CORP·Filed 2020·Application pending·0 cites
- 2658US2012034279A1Transscleral deliveryCOOPER EUGENE R·Filed 2011·Application pending·0 cites
- 2752US2006257450A1Drug delivery systems for treatment of diseases or conditionsMUDUMBA SREENIVASU·Filed 2006·Application pending·0 cites
- 2837US11285081B2Sealed preparation container and use for sameSANTEN PHARMACEUTICAL CO LTD·Filed 2018·Granted Mar 29, 2022·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Sreenivasu Mudumba files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →